中外製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2013/02/27 | 1,997 | 2,012 | 1,964 | 1,966 | -38 | -1.9% | 860,900 |
2013/02/26 | 2,007 | 2,017 | 1,991 | 2,004 | -53 | -2.6% | 1,398,800 |
2013/02/25 | 2,027 | 2,060 | 2,025 | 2,057 | +44 | +2.2% | 1,012,000 |
2013/02/22 | 1,980 | 2,018 | 1,978 | 2,013 | +26 | +1.3% | 1,049,900 |
2013/02/21 | 1,983 | 2,013 | 1,979 | 1,987 | -13 | -0.7% | 956,200 |
2013/02/20 | 1,989 | 2,003 | 1,981 | 2,000 | +30 | +1.5% | 1,164,600 |
2013/02/19 | 1,966 | 1,991 | 1,965 | 1,970 | -14 | -0.7% | 971,600 |
2013/02/18 | 1,960 | 1,994 | 1,957 | 1,984 | +42 | +2.2% | 1,034,900 |
2013/02/15 | 1,956 | 1,978 | 1,938 | 1,942 | -16 | -0.8% | 1,066,000 |
2013/02/14 | 1,951 | 1,975 | 1,941 | 1,958 | +25 | +1.3% | 1,184,900 |
2013/02/13 | 1,967 | 1,980 | 1,922 | 1,933 | -33 | -1.7% | 674,100 |
2013/02/12 | 1,949 | 1,980 | 1,949 | 1,966 | +53 | +2.8% | 952,600 |
2013/02/08 | 1,879 | 1,939 | 1,878 | 1,913 | -4 | -0.2% | 2,209,400 |
2013/02/07 | 1,924 | 1,925 | 1,905 | 1,917 | -10 | -0.5% | 1,093,000 |
2013/02/06 | 1,871 | 1,937 | 1,866 | 1,927 | +87 | +4.7% | 1,437,900 |
2013/02/05 | 1,838 | 1,872 | 1,835 | 1,840 | -2 | -0.1% | 1,046,600 |
2013/02/04 | 1,854 | 1,876 | 1,841 | 1,842 | -10 | -0.5% | 526,500 |
2013/02/01 | 1,864 | 1,884 | 1,851 | 1,852 | -29 | -1.5% | 912,600 |
2013/01/31 | 1,820 | 1,888 | 1,820 | 1,881 | +63 | +3.5% | 1,682,100 |
2013/01/30 | 1,790 | 1,818 | 1,773 | 1,818 | +56 | +3.2% | 1,412,600 |
2013/01/29 | 1,743 | 1,780 | 1,743 | 1,762 | -9 | -0.5% | 936,700 |
2013/01/28 | 1,807 | 1,820 | 1,768 | 1,771 | -19 | -1.1% | 791,900 |
2013/01/25 | 1,769 | 1,798 | 1,761 | 1,790 | +34 | +1.9% | 1,173,600 |
2013/01/24 | 1,713 | 1,759 | 1,703 | 1,756 | +21 | +1.2% | 1,207,100 |
2013/01/23 | 1,760 | 1,776 | 1,735 | 1,735 | -37 | -2.1% | 847,000 |
2013/01/22 | 1,782 | 1,794 | 1,751 | 1,772 | -3 | -0.2% | 1,031,300 |
2013/01/21 | 1,813 | 1,814 | 1,775 | 1,775 | -37 | -2% | 849,500 |
2013/01/18 | 1,795 | 1,815 | 1,792 | 1,812 | +45 | +2.5% | 1,078,400 |
2013/01/17 | 1,775 | 1,776 | 1,733 | 1,767 | -1 | -0.1% | 1,627,900 |
2013/01/16 | 1,800 | 1,806 | 1,766 | 1,768 | -29 | -1.6% | 1,066,900 |
2013/01/15 | 1,749 | 1,806 | 1,747 | 1,797 | +53 | +3% | 1,110,100 |
2013/01/11 | 1,725 | 1,758 | 1,722 | 1,744 | +39 | +2.3% | 2,105,900 |
2013/01/10 | 1,700 | 1,717 | 1,700 | 1,705 | +6 | +0.4% | 1,070,800 |
2013/01/09 | 1,679 | 1,707 | 1,666 | 1,699 | +8 | +0.5% | 1,057,300 |
2013/01/08 | 1,685 | 1,711 | 1,679 | 1,691 | +18 | +1.1% | 900,300 |
2013/01/07 | 1,683 | 1,689 | 1,672 | 1,673 | -10 | -0.6% | 899,100 |
2013/01/04 | 1,688 | 1,688 | 1,655 | 1,683 | +32 | +1.9% | 1,139,800 |
2012/12/28 | 1,664 | 1,665 | 1,647 | 1,651 | -9 | -0.5% | 942,200 |
2012/12/27 | 1,657 | 1,668 | 1,647 | 1,660 | +12 | +0.7% | 950,600 |
2012/12/26 | 1,644 | 1,648 | 1,624 | 1,648 | -8 | -0.5% | 1,077,600 |
2012/12/25 | 1,670 | 1,672 | 1,648 | 1,656 | +16 | +1% | 758,900 |
2012/12/21 | 1,682 | 1,682 | 1,639 | 1,640 | -21 | -1.3% | 1,622,000 |
2012/12/20 | 1,678 | 1,681 | 1,656 | 1,661 | -14 | -0.8% | 1,062,100 |
2012/12/19 | 1,663 | 1,675 | 1,643 | 1,675 | +24 | +1.5% | 1,083,300 |
2012/12/18 | 1,676 | 1,680 | 1,649 | 1,651 | -25 | -1.5% | 1,473,900 |
2012/12/17 | 1,660 | 1,679 | 1,649 | 1,676 | +41 | +2.5% | 1,825,300 |
2012/12/14 | 1,640 | 1,655 | 1,633 | 1,635 | -9 | -0.5% | 3,556,100 |
2012/12/13 | 1,659 | 1,659 | 1,637 | 1,644 | -6 | -0.4% | 994,500 |
2012/12/12 | 1,653 | 1,658 | 1,641 | 1,650 | +1 | +0.1% | 1,006,500 |
2012/12/11 | 1,650 | 1,656 | 1,638 | 1,649 | ±0 | ±0% | 1,012,200 |
3001~
3050
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
中外薬 | 761,900円 | +1.7% | +5.0% | 3.28% | 30.58倍 | 6.59倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 429,500円 | -1.1% | +75.3% | 4.66% | 29.42倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 348,500円 | +6.0% | +4.0% | 2.24% | 21.64倍 | 4.00倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 677,800円 | +2.2% | +10.2% | 1.77% | 13.02倍 | 1.31倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム